Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-12-17, Stock:JNJ, The news for the past five days is as follows:
2018-12-10: NEWS1: How Endo International’s Gross Margin Has Trended.NEWS2: PFE Stock Has Broken Its Slump and Could Challenge Former Highs.NEWS3: PFE Stock Has Broken Its Slump and Could Challenge Former Highs.NEWS4: The Zacks Analyst Blog Highlights: Apple, DowDuPont, Exxon Mobil, Johnson & Johnson and Verizon Communications.NEWS5: The Zacks Analyst Blog Highlights: Apple, DowDuPont, Exxon Mobil, Johnson & Johnson and Verizon Communications.NEWS6: The Zacks Analyst Blog Highlights: Apple, DowDuPont, Exxon Mobil, Johnson & Johnson and Verizon Communications.NEWS7: PFE Stock Has Broken Its Slump and Could Challenge Former Highs.NEWS8: Health Care Sector Update for 12/10/2018: AXON, MRNS, RARX, JNJ, PFE, MRK, ABT, AMGN.NEWS9: Health Care Sector Update for 12/10/2018: AXON, MRNS, RARX, JNJ, PFE, MRK, ABT, AMGN.NEWS10: Today's Research Reports on Trending Tickers: Johnson & Johnson and Bristol-Myers Squibb.NEWS11: Is Johnson & Johnson (JNJ) A Good Stock According To Hedge Funds?.NEWS12: Stock Market Power Rankings: Amazon Takes Control.NEWS13: Stock Market Power Rankings: Amazon Takes Control.
2018-12-11: NEWS1: Cramer: Pick individual stocks with long-term growth stories in this 'treacherous' market.NEWS2: Why Is Shopify Stock Holding Up While Others Can’t Handle The Turmoil?.NEWS3: Why Is Shopify Stock Holding Up While Others Can’t Handle The Turmoil?.NEWS4: Markets Right Now: Stock market ends mixed after a bumpy day.NEWS5: Will Wayfair Stock Remain a Safety Play During Market Turbulence?.NEWS6: Will Wayfair Stock Remain a Safety Play During Market Turbulence?.NEWS7: MYOS Muscling Up, CORT Turns Heads, Former FDA Official Joins PTE Board.NEWS8: MYOS Muscling Up, CORT Turns Heads, Former FDA Official Joins PTE Board.NEWS9: Today's Stock Market: Dow Jones Volatile After Trump Spars With Democratic Leaders.NEWS10: Understanding Regeneron Pharmaceuticals’ Operational Performance.NEWS11: Regeneron Pharmaceuticals’ Gross Margin Trends.NEWS12: What Are Tesaro’s Revenue Projections for Fiscal 2018?.NEWS13: Why Is Shopify Stock Holding Up While Others Can’t Handle The Turmoil?.NEWS14: Bristol-Myers to Study Opdivo in Combo With Vedanta's VE800.NEWS15: Bristol-Myers to Study Opdivo in Combo With Vedanta's VE800.NEWS16: Will Wayfair Stock Remain a Safety Play During Market Turbulence?.NEWS17: Bristol-Myers to Study Opdivo in Combo With Vedanta's VE800.NEWS18: Health Care Sector Update for 12/11/2018: ENTX, AMGN, ITCI, NVS, JNJ, PFE, MRK, ABT.NEWS19: Health Care Sector Update for 12/11/2018: ENTX, AMGN, ITCI, NVS, JNJ, PFE, MRK, ABT.NEWS20: How Much Upside Do Analysts Expect in Endo Stock?.NEWS21: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS22: Pennovation Center-based biotech startup raises $13M.NEWS23: What Endo International’s Bottom Line Trend Indicates.
2018-12-12: NEWS1: Why Arrowhead Pharmaceuticals Surged 11% Higher Today.NEWS2: Why Arrowhead Pharmaceuticals Surged 11% Higher Today.NEWS3: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS4: Why Arrowhead Pharmaceuticals Surged 11% Higher Today.NEWS5: J&J Reportedly Willing To Pay $400 Million-Plus In Hip-Device Cases.NEWS6: J&J Reportedly Willing To Pay $400 Million-Plus In Hip-Device Cases.NEWS7: J&J says its psoriasis drug superior to Novartis treatment in study.NEWS8: 5 Pharma Stocks That Could Cure Ailing Portfolios in 2019.NEWS9: 5 Pharma Stocks That Could Cure Ailing Portfolios in 2019.NEWS10: Health Care Sector Update for 12/12/2018: XBIT, SGYP, NBIX, MRNS, JNJ, PFE, MRK, ABT, AMGN.NEWS11: Health Care Sector Update for 12/12/2018: XBIT, SGYP, NBIX, MRNS, JNJ, PFE, MRK, ABT, AMGN.NEWS12: Portola (PTLA) Down as CHMP Defers Review Date for Ondexxya.NEWS13: Portola (PTLA) Down as CHMP Defers Review Date for Ondexxya.NEWS14: 5 Pharma Stocks That Could Cure Ailing Portfolios in 2019.NEWS15: Here's How to Survive a Stock Market Crash.NEWS16: Here's How to Survive a Stock Market Crash.NEWS17: Portola (PTLA) Down as CHMP Defers Review Date for Ondexxya.NEWS18: Health Care Sector Update for 12/12/2018: SGYP, NBIX, MRNS, JNJ, PFE, MRK, ABT, AMGN.NEWS19: Health Care Sector Update for 12/12/2018: SGYP, NBIX, MRNS, JNJ, PFE, MRK, ABT, AMGN.NEWS20: Do Analysts See Any Upside for Regeneron Stock?.NEWS21: Here&apos;s How to Survive a Stock Market Crash.NEWS22: What Regeneron Pharmaceuticals’ Bottom Line Indicates.NEWS23: J&J says its psoriasis drug superior to Novartis' in study.NEWS24: Arrowhead Pharmaceuticals (ARWR) Q4 2018 Earnings Conference Call Transcript.
2018-12-13: NEWS1: [$$] Battle Over Shareholder Suits Pulls In J&J.NEWS2: Health Care Sector Update for 12/13/2018: VBIV, AGTC, AMPE, JNJ, PFE, MRK, ABT, AMGN.NEWS3: Health Care Sector Update for 12/13/2018: VBIV, AGTC, AMPE, JNJ, PFE, MRK, ABT, AMGN.NEWS4: A Closer Look at Biogen’s Gross Margin Trends.NEWS5: J&J's Tremfya Beats Novartis' Cosentyx in Head-to-Head Study.NEWS6: J&J's Tremfya Beats Novartis' Cosentyx in Head-to-Head Study.NEWS7: Mallinckrodt's Roxicodone Reformulation Gets CRL From FDA.NEWS8: Mallinckrodt's Roxicodone Reformulation Gets CRL From FDA.NEWS9: Top 10 Healthcare Stories of 2018.NEWS10: Top 10 Healthcare Stories of 2018.NEWS11: Stocks - Ciena Jumps in Premarket, Apple Gains, Tailored Brands Crashes.NEWS12: Top 10 Healthcare Stories of 2018.NEWS13: J&J's Tremfya Beats Novartis' Cosentyx in Head-to-Head Study.NEWS14: 5 Dow Stocks Defying the Index's YTD Plunge.NEWS15: 5 Dow Stocks Defying the Index's YTD Plunge.NEWS16: 5 Dow Stocks Stand Tall Despite Index's Loss of 2018 Gains.NEWS17: 5 Dow Stocks Stand Tall Despite Index's Loss of 2018 Gains.NEWS18: Lilly Inks Deal With AC Immune for Potential Alzheimer's Drug.NEWS19: Lilly Inks Deal With AC Immune for Potential Alzheimer's Drug.NEWS20: Health Care Sector Update for 12/13/2018: AGTC, AMPE, VVUS, JNJ, PFE, ABT, MRK, AMGN.NEWS21: Health Care Sector Update for 12/13/2018: AGTC, AMPE, VVUS, JNJ, PFE, ABT, MRK, AMGN.NEWS22: Mallinckrodt's Roxicodone Reformulation Gets CRL From FDA.NEWS23: Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for December 14, 2018.NEWS24: Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for December 14, 2018.NEWS25: Lilly Inks Deal With AC Immune for Potential Alzheimer's Drug.NEWS26: Do Analysts See Any Upside for Abbott Stock?.NEWS27: Understanding Abbott Laboratories’ Operational Performance.NEWS28: Abbott Laboratories’ Gross Margin Trends.NEWS29: 5 Dow Stocks Stand Tall Despite Index's Loss of 2018 Gains.NEWS30: 5 Dow Stocks Defying the Index's YTD Plunge.NEWS31: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS32: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.
2018-12-14: NEWS1: Johnson & Johnson knew of asbestos in baby powder, report says.NEWS2: Why Johnson & Johnson, Costco, and Apple Slumped Today.NEWS3: Why Johnson & Johnson, Costco, and Apple Slumped Today.NEWS4: Why Johnson & Johnson Stock Crashed 10% Today.NEWS5: Why Johnson & Johnson Stock Crashed 10% Today.NEWS6: Negativity shouldn't stop you from careful stock-picking.NEWS7: Bragar Eagel & Squire, P.C. is Investigating Johnson & Johnson (JNJ) on Behalf of Stockholders and Encourages JNJ Investors to Contact the Firm.NEWS8: Cramer on the sell-off: Negativity shouldn't stop you fro....NEWS9: Cramer on the sell-off: Negativity shouldn&apos;t stop you from careful stock-picking.NEWS10: Cramer on the sell-off: Negativity shouldn't stop you from careful stock-picking.NEWS11: Cramer&apos;s game plan: Bargains may not be enough to attract buyers.NEWS12: Cramer's game plan: Bargains may not be enough to attract buyers.NEWS13: JNJ Stock Sinks on News Johnson & Johnson Knew About Abestos in Baby Powder.NEWS14: JNJ Stock Sinks on News Johnson & Johnson Knew About Abestos in Baby Powder.NEWS15: Dow Drops Nearly 500 Points; S&P Marks Lowest Close in Months.NEWS16: Dow Drops Nearly 500 Points; S&P Marks Lowest Close in Months.NEWS17: J&J hammered by report it knew of asbestos in baby powder.NEWS18: J&J hammered by report it knew of asbestos in baby powder.NEWS19: Cramer: When J&J continues falling on Monday it could be time to buy.NEWS20: Cramer: When J&J continues falling on Monday it could be time to buy.NEWS21: Business Highlights.NEWS22: Why Johnson & Johnson Stock Crashed 10% Today.NEWS23: Johnson & Johnson just posted its worst day since 2002.NEWS24: Close Update: Wall Street Skids As Global Recession Worries Resurface.NEWS25: Close Update: Wall Street Skids As Global Recession Worries Resurface.NEWS26: Hagens Berman Notifies Johnson & Johnson (JNJ) Investors of the Firm's Investigation of Possible Disclosure Violations.NEWS27: Commentary: J&J is a company of the 'highest integrity.' Investors overreact to asbestos report.NEWS28: Why Johnson & Johnson, Costco, and Apple Slumped Today.NEWS29: 8 Safe Stocks to Buy as Wall Street Goes Defensive.NEWS30: 8 Safe Stocks to Buy as Wall Street Goes Defensive.NEWS31: 5 Biggest Medtech Stocks -- Are They Buys?.NEWS32: 5 Biggest Medtech Stocks -- Are They Buys?.NEWS33: Johnson & Johnson knew about cancer-causing asbestos in baby powder for decades, new report claims.NEWS34: Market Close Report: NASDAQ Composite index closes at 6,910.67 down -159.66 points.NEWS35: Market Close Report: NASDAQ Composite index closes at 6,910.67 down -159.66 points.NEWS36: US STOCKS-Wall St tumbles on global growth worries, J&J decline.NEWS37: Johnson & Johnson, Adobe and Starbucks dip; Sealed Air rises.NEWS38: NOTICE TO CURRENT AND FORMER EMPLOYEES: Zamansky LLC Investigates the Johnson & Johnson Retirement Savings Plan for Possible ERISA Violations.NEWS39: Johnson & Johnson’s stock slammed after report it knew of asbestos in baby powder.NEWS40: Flashback Friday: Johnson & Johnson Hits Take Historic Plunge.NEWS41: J&J loses $39.8 billion in market value after report claims J&J knew about asbestos in baby powder.NEWS42: Buying Johnson & Johnson won't hurt your portfolio, says ....NEWS43: J&J knew for decades that asbestos lurked in its Baby Powder.NEWS44: Markets Right Now: S&P 500 sinks to lowest level since April.NEWS45: US STOCKS SNAPSHOT-Wall St tumbles on global economic worries; J&J drags S&P, Dow.NEWS46: Shareholder Alert: Thornton Law Firm LLP Notifies Shareholders Of Johnson & Johnson (JNJ) Of An Investigation Involving Possible Securities Fraud Related To Disclosure Of Baby Powder/Asbestos In J&J Products.NEWS47: Noteworthy Friday Option Activity: JNJ, ETFC, XRX.NEWS48: Noteworthy Friday Option Activity: JNJ, ETFC, XRX.NEWS49: Friday Sector Laggards: Energy, Healthcare.NEWS50: Friday Sector Laggards: Energy, Healthcare.NEWS51: Reuters stands by J&J report, says it was based 'entirely' on Johnson & Johnson documents.NEWS52: Healthcare ETFs Looked Pale on Reports J&J Knew About Asbestos in Baby Powder.NEWS53: J&J shares nosedive on baby powder worries.NEWS54: 5 Biggest Medtech Stocks -- Are They Buys?.NEWS55: US STOCKS-Global growth worries, J&J's tumble drag Wall St lower.NEWS56: Johnson & Johnson Shares Plunge After Report It Knew of Asbestos in Baby Powder.NEWS57: Dow Jones Today: Johnson & Johnson Stock Slammed On Asbestos Report.NEWS58: Johnson & Johnson Breaks Down Sharply on the Charts So Take Action.NEWS59: Markets Right Now: Stocks drop on China concerns, J&J sinks.NEWS60: J&J stock drop due more to time of year than Reuters head....NEWS61: From Fen-Phen to Vioxx: The biggest healthcare product liability settlements ever.NEWS62: J&J shares nosedive on report it knew of asbestos in Baby Powder.NEWS63: 12 Stocks You Should Never Sell.NEWS64: Health Care Sector Update for 12/14/2018: JNJ, KANG, AXON, PFE, ABT, MRK, AMGN.NEWS65: Health Care Sector Update for 12/14/2018: JNJ, KANG, AXON, PFE, ABT, MRK, AMGN.NEWS66: Those J&J Baby-Powder Lawsuits Aren&apos;t Going Away.NEWS67: J&J shares nosedive on report it knew of asbestos in Baby Powder.NEWS68: Statement on Reuters Talc Article.NEWS69: J&J Analysts Say Talc Report Is Old News While Stock Plummets.NEWS70: Reuters' Lisa Girion details her report on Johnson & John....NEWS71: INVESTOR ALERT: Ademi & O'Reilly, LLP Investigates Whether Johnson & Johnson (JNJ) Violated Securities Laws.NEWS72: Mid-Day Update: US Stocks Sell-Off As Global Growth Fears Resurface.NEWS73: Mid-Day Update: US Stocks Sell-Off As Global Growth Fears Resurface.NEWS74: US STOCKS-Global growth worries, J&J's tumble drag Wall St lower.NEWS75: Johnson & Johnson sell-off is 'excessive' in light of asbestos report, says Wells Fargo.NEWS76: Johnson & Johnson stock sinks on reports of asbestos in b....NEWS77: Wall Street Roiled by Soft Chinese, EU Economic Data.NEWS78: Wall Street Roiled by Soft Chinese, EU Economic Data.NEWS79: J&J Asbestos Report Pulls Health Care Stocks Down Midday.NEWS80: Johnson and Johnson knew its baby powder had asbestos for decades: Report.NEWS81: J&J shares nosedive on report company knew of asbestos in baby powder.NEWS82: Markets Right Now: Stocks drop on China concerns, J&J sinks.NEWS83: J&J&apos;s Intraday Plunge Wipes Out $45 Billion.NEWS84: Concerns About Global Economy Lead To Sell-Off On Wall Street - U.S. Commentary.NEWS85: Concerns About Global Economy Lead To Sell-Off On Wall Street - U.S. Commentary.NEWS86: Why Johnson & Johnson Is Down Over 8%.NEWS87: Johnson & Johnson shares fall on report of asbestos in ta....NEWS88: US STOCKS-Rising global growth fears pull down Wall Street.NEWS89: J&J shares sink 9% after Reuters report on asbestos in Johnson & Johnson baby powder.NEWS90: J&J shares sink 11% after Reuters report on asbestos in Johnson & Johnson baby powder.NEWS91: J&J reportedly knew about asbestos in baby powder for decades, shares drop 8%.NEWS92: J&J is emblematic of what's going on with this market, sa....NEWS93: Johnson & Johnson shares drop on Reuters report that the company knew for decades of asbestos in its baby powder.NEWS94: 5 Drug/Biotech Stocks With Promise to Sustain Bull Run in 2019.NEWS95: Pharma Stock Roundup: AZN, RHHBY Cancer Drugs, LLY, BMY New Deals in Focus.NEWS96: Johnson & Johnson Down 8% On Report Of Asbestos In Baby Powder.NEWS97: Johnson & Johnson Down 8% On Report Of Asbestos In Baby Powder.NEWS98: Do Analysts See Any Upside for Biogen Stock?.NEWS99: J&J Posting Steep Loss On Reported Knowledge Of Asbestos In Baby Powder.NEWS100: J&J Posting Steep Loss On Reported Knowledge Of Asbestos In Baby Powder.NEWS101: Stocks Seeing Further Downside In Mid-Day Trading - U.S. Commentary.NEWS102: Stocks Seeing Further Downside In Mid-Day Trading - U.S. Commentary.NEWS103: Stocks Remain Firmly Negative After Initial Sell-Off - U.S. Commentary.NEWS104: Stocks Remain Firmly Negative After Initial Sell-Off - U.S. Commentary.NEWS105: [$$] J&J shares dive on report company knew of asbestos in baby powder.NEWS106: [$$] Wall Street down more than 1% on Chinese growth worries.NEWS107: [$$] Johnson & Johnson Drafted Into Fight Over Shareholder Lawsuits.NEWS108: Janssen's Daratumumab SNDA In Japan Triggers $2 Mln Milestone Payment To Genmab.NEWS109: Janssen's Daratumumab SNDA In Japan Triggers $2 Mln Milestone Payment To Genmab.

Answer: Decrease